activity
20242026
collaborators

6 papers

q-bio.QM2026

Habitual lifestyle timing explains circadian timing, but daily lifestyle changes do not, in free-living humans across 2000 days

Billy C. Smith, Zeel Pansara, Rosanne H. Timmerman +11

Background: Both between- and within-subject variations in circadian timing matter for health. If lifestyle changes could be used to regulate circadian timing, they would offer acc…

q-bio.QM2025

Multimodal Modeling of Ultradian Rhythms Using the Hankel Alternative View of Koopman (HAVOK) Analysis

Emmanuel Molefi, Billy C. Smith, Christopher Thornton +2

Ultradian rhythms - quasi-rhythmic fluctuations in behavior and physiology with periods shorter than 24 hours - are observed across various organisms, including humans. Despite the…

q-bio.NC2025

Dual mechanism of Anti-Seizure Medications in controlling seizure activity

Guillermo M. Besne, Emmanuel Molefi, Sarah J. Gascoigne +12

Background: Anti-seizure medications (ASMs) can reduce seizure duration, but their precise modes of action are unclear. Specifically, it is unknown whether ASMs shorten seizures by…

q-bio.NC2025

More variable circadian rhythms in epilepsy captured by long-term heart rate recordings from wearable sensors

Billy C. Smith, Christopher Thornton, Rachel E. Stirling +7

Objective: The circadian rhythm synchronizes physiological and behavioural patterns with the 24-hour light-dark cycle. Disruption to the circadian rhythm is linked to various healt…

q-bio.NC2024

Comparing Methodological Variations in Seizure Onset Localisation Algorithms using intracranial EEG

Sarah J. Gascoigne, Manel Vila-Vidal, Nathan Evans +9

During clinical treatment for epilepsy, the area of the brain thought to be responsible for pathological activity is identified. This identification is typically performed through…

q-bio.NC2024

Anti-seizure medication tapering correlates with daytime delta band power reduction in the cortex

Guillermo M. Besne, Nathan Evans, Mariella Panagiotopoulou +11

Anti-seizure medications (ASMs) are the primary treatment for epilepsy, yet medication tapering effects have not been investigated in a dose, region, and time-dependent manner, des…